Delve into the current trends and future directions in breast cancer care, with a focus on personalized treatment plans, breakthrough research, and survivorship care. The program will feature presentations and discussions led by leading experts in the field, offering insights into the latest advancements in breast cancer diagnostics, treatment protocols, and patient management strategies. Attendees will gain a deeper understanding of innovative therapies and the impact of emerging technologies on patient outcomes. Additionally, the conference will address the psychosocial aspects of breast cancer survivorship, highlighting comprehensive care approaches that support patients’ long-term well-being.
*Biopharmaceutical industry attendance is restricted to event sponsors only. For sponsorship information, please email katrina@flasco.org
Meeting Handout
Presentations
9:00 – 9:30am
“Standards and Advances in Early Stage Triple Negative Breast Cancer” – Coy Heldermon, MD, PhD
9:30 – 10:00am
“Personalizing Treatment: Metastatic Triple Negative Breast Cancer” – Victoria Rizk, MD
10:00 – 10:30am
“Hormone Sensitive Breast Cancer: Early Stage Management” – Lauren Carcas, MD
10:30 – 11:00am
“Treatment Approaches for HR+/HER2- Metastatic Breast Cancer” – Reshma Mahtani, DO
11:30am – 12:00pm
“Updates in Early Stage HER2 Positive Breast Cancer” – Avan Armaghani, MD, FACP
12:00 – 12:30pm
“Updates in Treatment for Metastatic HER2-Positive Breast Cancer” – Saranya Chumsri, MD
1:30 – 2:00pm
“Breast Cancer Survivorship – The Gift That Keeps on Giving” – Carmen Calfa, MD
3:00 – 3:30pm
“Updates in Radiation for the Management of Early-Stage Breast Cancer” – Catherine (Sue) Hwang, MD
3:30 – 4:00pm
“Pathology & Genetics: Is It Time To Retire The Term of Cancer in Low-Grade DCIS?” – Shahlda Masood, MD, FACP
Photos
